Ribosome-mediated synthesis of natural product-like peptides via cell-free translation

Current Opinion in Chemical Biology

Volumn 34, Issue , 2016, Pages 44-52

  Maini, Rumit ^a   Umemoto, Shiori ^a   Suga, Hiroaki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO AMINO ACID; NATURAL PRODUCT; PEPTIDE; SYNTHETIC PEPTIDE; AMINO ACID; BIOLOGICAL PRODUCT;

BIOTECHNOLOGY; CYCLIZATION; PEPTIDE LIBRARY; PEPTIDE SYNTHESIS; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; RIBOSOME; RNA TRANSLATION; CELL FREE SYSTEM; METABOLISM; PROTEIN SYNTHESIS;

AMINO ACIDS; BIOLOGICAL PRODUCTS; CELL-FREE SYSTEM; CYCLIZATION; PEPTIDES; PROTEIN BIOSYNTHESIS; RIBOSOMES;

EID: 84975456513     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2016.06.006     Document Type: Review

References (72)

1. Josephson K., Ricardo A., Szostak J.W. mRNA display: from basic principles to macrocycle drug discovery. Drug Discov Today 2014, 19:388-399.
2. Passioura T., Katoh T., Goto Y., Suga H. Selection-based discovery of druglike macrocyclic peptides. Annu Rev Biochem 2014, 83:727-752.
3. Hipolito C.J., Suga H. Ribosomal production and in vitro selection of natural product-like peptidomimetics: the FIT and RAPID systems. Curr Opin Chem Biol 2012, 16:196-203.
4. Frost J.R., Smith J.M., Fasan R. Design, synthesis, and diversification of ribosomally derived peptide macrocycles. Curr Opin Struct Biol 2013, 23:571-580.
5. Ishizawa T., Kawakami T., Reid P.C., Murakami H. TRAP display: a high-speed selection method for the generation of functional polypeptides. J Am Chem Soc 2013, 135:5433-5440.
6. Hipolito C.J., Bashiruddin N.K., Suga H. Protein cocrystallization molecules originating from in vitro selected macrocyclic peptides. Curr Opin Struct Biol 2014, 26:24-31.
7. Manandhar Y., Bahadur K.C., Wang W., Uzawa T., Aigaki T., Ito Y. In vitro selection of a peptide aptamer that changes fluorescence in response to verotoxin. Biotechnol Lett 2015, 37:619-625.
8. Wang W., Uzawa T., Tochio N., Hamatsu J., Hirano Y., Tada S., Saneyoshi H., Kigawa T., Hayashi N., Ito Y., Taiji M., et al. A fluorogenic peptide probe developed by in vitro selection using tRNA carrying a fluorogenic amino acid. Chem Commun (Camb) 2014, 50:2962-2964.
9. Iwasaki K., Goto Y., Katoh T., Yamashita T., Kaneko S., Suga H. A fluorescent imaging probe based on a macrocyclic scaffold that binds to cellular EpCAM. J Mol Evol 2015, 81:210-217.
10. Khan A.R., Parrish J.C., Fraser M.E., Smith W.W., Bartlett P.A., James M.N. Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes. Biochemistry 1998, 37:16839-16845.
11. Mallinson J., Collins I. Macrocycles in new drug discovery. Future Med Chem 2012, 4:1409-1438.
12. Rezai T., Yu B., Millhauser G.L., Jacobson M.P., Lokey R.S. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J Am Chem Soc 2006, 128:2510-2511.
13. Hewitt W.M., Leung S.S., Pye C.R., Ponkey A.R., Bednarek M., Jacobson M.P., Lokey R.S. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products. J Am Chem Soc 2015, 137:715-721.
14. Morioka T., Loik N.D., Hipolito C.J., Goto Y., Suga H. Selection-based discovery of macrocyclic peptides for the next generation therapeutics. Curr Opin Chem Biol 2015, 26:34-41.
15. Bashiruddin N.K., Suga H. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies. Curr Opin Chem Biol 2015, 24:131-138.
16. Knerr P.J., van der Donk W.A. Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 2012, 81:479-505.
17. Seebeck F.P., Ricardo A., Szostak J.W. Artificial lantipeptides from in vitro translation. Chem Commun 2011, 47:6141-6143.
18. Hofmann F.T., Szostak J.W., Seebeck F.P. In vitro selection of functional lantipeptides. J Am Chem Soc 2012, 134:8038-8041.
19. Goto Y., Ohta A., Sako Y., Yamagishi Y., Murakami H., Suga H. Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides. ACS Chem Biol 2008, 3:120-129.
20. Goto Y., Suga H. Flexizymes as a tRNA acylation tool facilitating genetic code reprogramming. Methods Mol Biol (Clifton, NJ) 2012, 848:465-478.
21. Passioura T., Suga H. Flexizymes, their evolutionary history and diverse utilities. Top Curr Chem 2014, 344:331-345.
22. Passioura T., Suga H. Flexizyme-mediated genetic reprogramming as a tool for noncanonical peptide synthesis and drug discovery. Chemistry (Weinheim an der Bergstrasse, Germany) 2013, 19:6530-6536.
23. Terasaka N., Suga H. Flexizymes-facilitated genetic code reprogramming leading to the discovery of drug-like peptides. Chem Lett 2013.
24. Goto Y., Katoh T., Suga H. Flexizymes for genetic code reprogramming. Nat Protoc 2011, 6:779-790.
25. Morimoto J., Hayashi Y., Suga H. Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase sirt2. Angew Chem Int Ed Engl 2012, 51:3423-3427.
26. Yamagishi Y., Shoji I., Miyagawa S., Kawakami T., Katoh T., Goto Y., Suga H. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. Chem Biol 2011, 18:1562-1570.
27. Ito K., Sakai K., Suzuki Y., Ozawa N., Hatta T., Natsume T., Matsumoto K., Suga H. Artificial human met agonists based on macrocycle scaffolds. Nat Commun 2015, 6:6373.
28. Bayo-Puxan N., Rodriguez-Mias R., Goldflam M., Kotev M., Ciudad S., Hipolito C.J., Varese M., Suga H., Campos-Olivas R., Barril X., Guallar V., et al. Combined use of oligopeptides, fragment libraries, and natural compounds: a comprehensive approach to sample the druggability of vascular endothelial growth factor. ChemMedChem 2015.
29. Sako Y., Goto Y., Murakami H., Suga H. Ribosomal synthesis of peptidase-resistant peptides closed by a nonreducible inter-side-chain bond. ACS Chem Biol 2008, 3:241-249.
30. Tanaka Y., Hipolito C.J., Maturana A.D., Ito K., Kuroda T., Higuchi T., Katoh T., Kato H.E., Hattori M., Kumazaki K., Tsukazaki T., et al. Structural basis for the drug extrusion mechanism by a mate multidrug transporter. Nature 2013, 496:247-251.
31. Sako Y., Morimoto J., Murakami H., Suga H. Ribosomal synthesis of bicyclic peptides via two orthogonal inter-side-chain reactions. J Am Chem Soc 2008, 130:7232-7234.
32. Bashiruddin N.K., Nagano M., Suga H. Synthesis of fused tricyclic peptides using a reprogrammed translation system and chemical modification. Bioorg Chem 2015, 61:45-50.
33. Lian W., Upadhyaya P., Rhodes C.A., Liu Y., Pei D. Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-alpha antagonist. J Am Chem Soc 2013, 135:11990-11995.
34. Angelini A., Cendron L., Chen S., Touati J., Winter G., Zanotti G., Heinis C. Bicyclic peptide inhibitor reveals large contact interface with a protease target. ACS Chem Biol 2012, 7:817-821.
35. Zhao G., Yuan C., Wind T., Huang Z., Andreasen P.A., Huang M. Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1. J Struct Biol 2007, 160:1-10.
36. Iwasaki K., Goto Y., Katoh T., Suga H. Selective thioether macrocyclization of peptides having the N-terminal 2-chloroacetyl group and competing two or three cysteine residues in translation. Org Biomol Chem 2012, 10:5783-5786.
37. Hong S.Y., Oh J.E., Lee K.H. Effect of d-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol 1999, 58:1775-1780.
38. 2: spectroscopic evidence for a peptide with significant .Beta.-turn character in water and in dimethyl sulfoxide. J Am Chem Soc 1992, 114:3182-3188.
39. Goto Y., Murakami H., Suga H. Initiating translation with d-amino acids. RNA (New York, NY) 2008, 14:1390-1398.
40. Kawakami T., Murakami H., Suga H. Ribosomal synthesis of polypeptoids and peptoid-peptide hybrids. J Am Chem Soc 2008, 130:16861-16863.
41. Fujino T., Goto Y., Suga H., Murakami H. Reevaluation of the d-amino acid compatibility with the elongation event in translation. J Am Chem Soc 2013, 135:1830-1837.
42. Yang X., van der Donk W.A. Post-translational introduction of d-alanine into ribosomally synthesized peptides by the dehydroalanine reductase npnj. J Am Chem Soc 2015, 137:12426-12429.
43. Chatterjee J., Gilon C., Hoffman A., Kessler H. N-methylation of peptides: a new perspective in medicinal chemistry. Acc Chem Res 2008, 41:1331-1342.
44. Beck J.G., Chatterjee J., Laufer B., Kiran M.U., Frank A.O., Neubauer S., Ovadia O., Greenberg S., Gilon C., Hoffman A., Kessler H. Intestinal permeability of cyclic peptides: common key backbone motifs identified. J Am Chem Soc 2012, 134:12125-12133.
45. Frankel A., Millward S.W., Roberts R.W. Encodamers: unnatural peptide oligomers encoded in RNA. Chem Biol 2003, 10:1043-1050.
46. Ovadia O., Greenberg S., Chatterjee J., Laufer B., Opperer F., Kessler H., Gilon C., Hoffman A. The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Mol Pharm 2011, 8:479-487.
47. Ahlbach C.L., Lexa K.W., Bockus A.T., Chen V., Crews P., Jacobson M.P., Lokey R.S. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products. Future Med Chem 2015, 7:2121-2130.
48. Finking R., Marahiel M.A. Biosynthesis of nonribosomal peptides. Annu Rev Microbiol 2004, 58:453-488.
49. Sieber S.A., Marahiel M.A. Molecular mechanisms underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem Rev 2005, 105:715-738.
50. Ellman J.A., Mendel D., Schultz P.G. Site-specific incorporation of novel backbone structures into proteins. Science 1992, 255:197-200.
51. Merryman C., Green R. Transformation of aminoacyl tRNAs for the in vitro selection of "drug-like" molecules. Chem Biol 2004, 11:575-582.
52. Subtelny A.O., Hartman M.C., Szostak J.W. Ribosomal synthesis of N-methyl peptides. J Am Chem Soc 2008, 130:6131-6136.
53. Kawakami T., Murakami H., Suga H. Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides. Chem Biol 2008.
54. Kawakami T., Ishizawa T., Fujino T., Reid P.C., Suga H., Murakami H. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells. ACS Chem Biol 2013, 8:1205-1214.
55. Kawakami T., Murakami H., Suga H. Ribosomal synthesis of polypeptoids and peptoid-peptide hybrids. J Am Chem Soc 2008, 130:16861-16863.
56. Schwochert J., Turner R., Thang M., Berkeley R.F., Ponkey A.R., Rodriguez K.M., Leung S.S., Khunte B., Goetz G., Limberakis C., Kalgutkar A.S., et al. Peptide to peptoid substitutions increase cell permeability in cyclic hexapeptides. Org Lett 2015, 17:2928-2931.
57. Schlippe Y.V., Hartman M.C., Josephson K., Szostak J.W. In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors. J Am Chem Soc 2012, 134:10469-10477.
58. Yamagata K., Goto Y., Nishimasu H., Morimoto J., Ishitani R., Dohmae N., Takeda N., Nagai R., Komuro I., Suga H., Nureki O. Structural basis for potent inhibition of SIRT2 deacetylase by a macrocyclic peptide inducing dynamic structural change. Structure 2014, 22:345-352.
59. Hipolito C.J., Tanaka Y., Katoh T., Nureki O., Suga H. A macrocyclic peptide that serves as a cocrystallization ligand and inhibits the function of a mate family transporter. Molecules 2013, 18:10514-10530.
60. Kodan A., Yamaguchi T., Nakatsu T., Sakiyama K., Hipolito C.J., Fujioka A., Hirokane R., Ikeguchi K., Watanabe B., Hiratake J., Kimura Y., et al. Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog. Proc Natl Acad Sci U S A 2014, 111:4049-4054.
61. Davis L., Chin J.W. Designer proteins: applications of genetic code expansion in cell biology. Nat Rev Mol Cell Biol 2012, 13:168-182.
62. Arnison P.G., Bibb M.J., Bierbaum G., Bowers A.A., Bugni T.S., Bulaj G., Camarero J.A., Campopiano D.J., Challis G.L., Clardy J., Cotter P.D., et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 2013, 30:108-160.
63. Blunt J.W., Copp B.R., Keyzers R.A., Munro M.H., Prinsep M.R. Marine natural products. Nat Prod Rep 2014, 31:160-258.
64. Cragg G.M., Newman D.J. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013, 1830:3670-3695.
65. Fujino T., Goto Y., Suga H., Murakami H. Ribosomal synthesis of peptides with multiple β-amino acids. Journal of the American Chemical Society 2016, 138:1962-1969.
66. Dedkova L.M., Fahmi N.E., Paul R., del Rosario M., Zhang L., Chen S., Feder G., Hecht S.M. β-Puromycin selection of modified ribosomes for in vitro incorporation of β-amino acids. Biochemistry 2012, 51:401-415.
67. Maini R., Chowdhury S.R., Dedkova L.M., Roy B., Daskalova S.M., Paul R., Chen S., Hecht S.M. Protein synthesis with ribosomes selected for the incorporation of β-amino acids. Biochemistry 2015, 54:3694-3706.
68. Maini R., Nguyen D.T., Chen S., Dedkova L.M., Chowdhury S.R., Alcala-Torano R., Hecht S.M. Incorporation of β-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center. Bioorg Med Chem 2013, 21:1088-1096.
69. Maini R., Dedkova L.M., Paul R., Madathil M.M., Chowdhury S.R., Chen S., Hecht S.M. Ribosome-mediated incorporation of dipeptides and dipeptide analogues into proteins in vitro. J Am Chem Soc 2015, 137:11206-11209.
70. Hudson G.A., Zhang Z., Tietz J.I., Mitchell D.A., van der Donk W.A. In vitro biosynthesis of the core scaffold of the thiopeptide thiomuracin. J Am Chem Soc 2015, 137:16012-16015.
71. Goto Y., Ito Y., Kato Y., Tsunoda S., Suga H. One-pot synthesis of azoline-containing peptides in a cell-free translation system integrated with a posttranslational cyclodehydratase. Chem Biol 2014, 21:766-774.
72. Torikai K., Suga H. Ribosomal synthesis of an amphotericin-B inspired macrocycle. J Am Chem Soc 2014, 136:17359-17361.